Ive been in and out since the $2 range.First real test of $40 in 2 momths.Volume is low because of December.Make make no mistake.The January effect should bringthis back over $50.Not he the stock you want to be shorting into January.
$TNDM was once a $300 stock, struggled on sales and debt. At the time, they did not have the supreme product and it crashed. Compare to $PODD Omnipod that only has bolus and you have to manually suspend, you would want to be with t-slim if you are a diabetic patient. T-slim x2 is marketed globally, sales are up on Q2. Expecting a BIG Q3 from these guys. Pullback?...
Bullish divergence in Stochastic, Chaiken Money Flow, where the momentum is printing higher lows. Money is flowing into the ticker since late October as price was moving lower so the dips were being picked up, perhaps a significant movement to the upside is expected for the year end?
8 Sec Filings today, here's one: investor.tandemdiabetes.com They're buying, I like this stock let's see. Yes, it's a bear market i know.
Trading Methodology: 1. An asymmetric bullish/bearish pennant is drawn using ascending and descending curved trend lines with a minimum of three price action touche points per line. The direction is determined by the previous trend. 2. The angle tool is applied from the earliest two trend touch points, beginning at the earliest touch point. 3. A trend-based...
Poor financials. Overpriced from a fundamental perspective. Plus chart looks negative, especially on monthly.
Sep-26-18 Reiterated Piper Jaffray Overweight $32 to $56 Sep-26-18 Reiterated Dougherty & Company Buy $45 to $56 -31.25% off 52 wk high, pullback to somewhere around $31 while the market sell-off. We should be good to go for another run. BUY. Your decision if you want to hold through earnings this October. Let me know
The recent analyst day was great, in my opinion, with strong product pipeline which should be followed by strong delivery. Guidance is up and most likely conservative going into next month's earnings call. Short term headwinds with regards to overbought status should dissipate soon as Tandem is far from being overbought. It has a strong chance of becoming a market...
Yesterday TNDM showed a big sell off ,similar to as it showed couple of weeks ago . If it goes below it price range then it's likely to show a downward staircase pattern . What are your thought ?
Bounced off support. Ascended Triangle patter. RSI = Not overbought, Room for growth. Strong guidance and product.
On this week I will look for a LONG on TNDM while daily RSI14 moving towards 75, daily price>SMA20 and while XLV sector continues to rally on its daily chart. SL 2.34% TP 7.02%
sell off to cool down then anaylst upgrades on the 26th with pump
Recent analyst downgrade was no less than pure manipulation to create new long term holders, most likely institutional holders as we are approaching the Sep 25th conference. Most analysts are still bullish, and there are several catalysts ahead through 2020 like t:sport, Control-IQ, sales on Basal-IQ, international expansion, and possible UHC coverage. Tandem also...
watch video for details
Youtube - DonFronShow Entered a buy zone with rejection and continuation of the uptrend pattern